dipyridamole has been researched along with Respiratory Tract Diseases in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prevailing influenza viruses causing epidemic in 1990-1991, 1991-1992 were A(H3N2) and B, respectively; ARD were caused by parainfluenza viruses, PC, P, mycoplasma etc." | 1.31 | [Epidemiologic and economic efficacy of massive prophylaxis of influenza and other acute respiratory viral infections using curantil in Moscow enterprises]. ( Fedorova, GI; Slepushkin, AN, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedorova, GI | 1 |
| Slepushkin, AN | 1 |
1 other study available for dipyridamole and Respiratory Tract Diseases
| Article | Year |
|---|---|
[Epidemiologic and economic efficacy of massive prophylaxis of influenza and other acute respiratory viral infections using curantil in Moscow enterprises].
Topics: Acute Disease; Cost-Benefit Analysis; Dipyridamole; Humans; Influenza, Human; Moscow; Occupational H | 2002 |